回望过去，细数SGLT2抑制剂跨越百年的成长历史1835年早在1835年，法国科学家克里斯托夫·彼得森首次从苹果树的根皮中分离出一种黄酮类化合物，命名为根皮苷（phlorizin），这是已知的第一个具有SGLT抑制活性的天然产物[1,2]。1886年 ...

Chronic Kidney Disease (CKD) indicates prolonged kidney damage over three months, often undetectable until significant harm occurs. Key risk factors include diabetes, high blood pressure ...

Cystatin C is emphasized as a preferred biomarker for accurate GFR measurement in CKD assessment. SGLT2i are recommended for CKD patients, regardless of diabetes status, for kidney and ...